These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 22305512)

  • 41. Opioid titration with sustained-release oxycodone and immediate-release morphine for moderate/severe cancer pain: a pilot assessment of the CoDem protocol.
    Samolsky Dekel BG; Tomasi M; Vasarri A; Gori A; Adversi M; Castagnoli A; Di Nino G; Melotti RM
    J Opioid Manag; 2014; 10(1):29-38. PubMed ID: 24604567
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Switching from oral oxycodone to oxycodone injection - an investigation into the dosage amount ratio].
    Oda K; Kamiyama H; Goda Y
    Gan To Kagaku Ryoho; 2015 Jan; 42(1):63-6. PubMed ID: 25596681
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Oral versus intravenous opioid dosing for the initial treatment of acute musculoskeletal pain in the emergency department.
    Miner JR; Moore J; Gray RO; Skinner L; Biros MH
    Acad Emerg Med; 2008 Dec; 15(12):1234-40. PubMed ID: 18945240
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Randomized, double-blind, cross-over trial comparing safety and efficacy of oral controlled-release oxycodone with controlled-release morphine in patients with cancer pain.
    Bruera E; Belzile M; Pituskin E; Fainsinger R; Darke A; Harsanyi Z; Babul N; Ford I
    J Clin Oncol; 1998 Oct; 16(10):3222-9. PubMed ID: 9779695
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [New option in the management of cancer pain in Hungary: short acting oral opioid therapy].
    Kullmann T; Sipőcz I; Csikós Á; Pintér T
    Orv Hetil; 2015 Jun; 156(25):1003-6. PubMed ID: 26170088
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Co-administration of oxycodone and morphine and analgesic synergy re-examined.
    Smith MT; de la Iglesia FA
    Br J Clin Pharmacol; 2005 Apr; 59(4):486-7; author reply 487-8. PubMed ID: 15801946
    [No Abstract]   [Full Text] [Related]  

  • 47. Switching from morphine to methadone to improve analgesia and tolerability in cancer patients: a prospective study.
    Mercadante S; Casuccio A; Fulfaro F; Groff L; Boffi R; Villari P; Gebbia V; Ripamonti C
    J Clin Oncol; 2001 Jun; 19(11):2898-904. PubMed ID: 11387363
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Use of opioids against severe cancer pain].
    Borchgrevink PC; Klepstad P; Kongsgaard UE; Kaasa S
    Tidsskr Nor Laegeforen; 2004 Feb; 124(3):337-8. PubMed ID: 14963506
    [No Abstract]   [Full Text] [Related]  

  • 49. A German model for methadone conversion.
    Nauck F; Ostgathe C; Dickerson ED
    Am J Hosp Palliat Care; 2001; 18(3):200-2. PubMed ID: 11406897
    [No Abstract]   [Full Text] [Related]  

  • 50. Oral oxycodone: new preparation. No better than oral morphine.
    Prescrire Int; 2003 Jun; 12(65):83-4. PubMed ID: 12825566
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Morphine-methadone opioid rotation in cancer patients: analysis of dose ratio predicting factors.
    Benítez-Rosario MA; Salinas-Martín A; Aguirre-Jaime A; Pérez-Méndez L; Feria M
    J Pain Symptom Manage; 2009 Jun; 37(6):1061-8. PubMed ID: 19171458
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Morphine or oxycodone for cancer-related pain? A randomized, open-label, controlled trial.
    Riley J; Branford R; Droney J; Gretton S; Sato H; Kennett A; Oyebode C; Thick M; Wells A; Williams J; Welsh K; Ross J
    J Pain Symptom Manage; 2015 Feb; 49(2):161-72. PubMed ID: 24975432
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Equianalgesia: applying evidence-based practice guidelines.
    Bond BS
    Clin J Oncol Nurs; 2008 Jun; 12(3):527-9. PubMed ID: 18515253
    [No Abstract]   [Full Text] [Related]  

  • 54. Opioid agonist doses for oxycodone and morphine dependence: Findings from a retrospective case series.
    Nielsen S; Bruno R; Degenhardt L; Demirkol A; Lintzeris N
    Drug Alcohol Rev; 2017 May; 36(3):311-316. PubMed ID: 27273511
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dose ratio between morphine and methadone in patients with cancer pain: a retrospective study.
    Lawlor PG; Turner KS; Hanson J; Bruera ED
    Cancer; 1998 Mar; 82(6):1167-73. PubMed ID: 9506365
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Switching from methadone to tapentadol for cancer pain.
    Mercadante S; Ferrera P; Adile C
    J Pain Symptom Manage; 2012 Sep; 44(3):e3-5. PubMed ID: 22819437
    [No Abstract]   [Full Text] [Related]  

  • 57. A Comparative Study of Opioid Switching to Methadone for Cancer Pain Control in Successful and Unsuccessful Cases.
    Okayama S; Matsuda Y; Yoshikawa Y
    J Palliat Med; 2019 Jul; 22(7):844-847. PubMed ID: 30716000
    [No Abstract]   [Full Text] [Related]  

  • 58. An ad libitum schedule for conversion of morphine to methadone in advanced cancer patients: an open uncontrolled prospective study in a Chinese population.
    Tse DM; Sham MM; Ng DK; Ma HM
    Palliat Med; 2003 Mar; 17(2):206-11. PubMed ID: 12701853
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Strategies for the treatment of cancer pain in the new millennium.
    Ripamonti C; Dickerson ED
    Drugs; 2001; 61(7):955-77. PubMed ID: 11434451
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficacy and safety of dual-opioid therapy in acute pain.
    Webster L
    Pain Med; 2012 Mar; 13 Suppl 1():S12-20. PubMed ID: 22420602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.